Reimbursement
Transparency isn't here yet and even then it will only be part of the answer.
Leaders of two warring healthcare healthcare institutions argue that a near-duopoly will benefit consumers and patients. The trouble is that a 60-year-old piece of the tax code leaves many without real choice.
The states that set up their own insurance marketplaces have nothing to lose in King v. Burwell, the big Supreme Court case that will be decided by the end of June. But that doesn't mean those states are breathing easy.
Pennsylvania is the first state to have a backup plan to prevent its residents from losing their health insurance subsidies should the U.S. Supreme Court strike down the federal exchange provision in the Affordable Care Act.
At the annual assembly of America's health insurance leaders, the need for better consumer experiences and more affordability goes without saying. The trouble is transcending the inertia of the old ways.
Where do health insurers fit into the convergence in healthcare, if anywhere? All problems are also opportunities, even if it might be in disguise.
No industry is immune from self-deprecation.
From behavioral health to oncology, UnitedHealth Group's bustling management and technology subsidiary is trying to synchronize healthcare for populations, providers and individuals.
Americans in public exchange plans are using their benefits, especially for prescription drugs, although in some ways it's different than other health plan segments.
The Obama administration has posted the 2016 rate increases in excess of 10 percent that the Obamacare health plans are requesting. There are a lot of them.